StockNews.com began coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report published on Saturday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

Nevro Corp. NVRO reported a loss per share of 64 cents in the fourth quarter of 2024, wider than the year-ago quarter’s loss of 15 cents. The Zacks Consensus Estimate is pegged at a loss per ...

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Nevro Corp. (NVRO) on Tuesday reported a loss of $53.1 million in its fourth quarter. On a per-share basis, the Redwood City ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp ... performance of its implantable devices, biologics, accessories and unique surgical instruments used in ...

As previously announced on February 6, given the pending acquisition of Nevro (NVRO) by Globus Medical, Nevro is not issuing FY25 guidance, nor is the company holding an earnings conference call ...

Nevro Corp是一家全球医疗器械公司，专注于提供继续为慢性疼痛治疗持久患者结果设定标准的全面的、改变生活的解决方案。该公司开发并商业化Senza脊髓刺激（SCS）系统。SCS是一个用于治疗慢性疼痛的神经调节平台，除了Senza系列产品之外，还包括Senza Omnia平台 ...

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Nevro Corp. (NVRO) on Tuesday reported a loss of $53.1 million in its fourth quarter. The Redwood City, California-based company said it ...